Declared Dividend • Apr 23
Dividend reduced to zł2.65 Dividend of zł2.65 is 48% lower than last year. Ex-date: 24th April 2026 Payment date: 30th April 2026 Dividend yield will be 3.9%, which is lower than the industry average of 12%. Sustainability & Growth Dividend is covered by both earnings (69% earnings payout ratio) and cash flows (71% cash payout ratio). The dividend has increased by an average of 3.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 97% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • Apr 02
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.4% net profit margin). Major Estimate Revision • Mar 31
Consensus revenue estimates fall by 11% The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from zł2.17b to zł1.94b. EPS estimate fell from zł7.37 to zł5.73 per share. Net income forecast to grow 89% next year vs 29% growth forecast for Chemicals industry in Poland. Consensus price target down from zł85.65 to zł81.80. Share price rose 4.1% to zł66.00 over the past week. New Risk • Mar 27
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.4% Last year net profit margin: 7.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (3.4% net profit margin). Announcement • Mar 27
PCC Rokita SA, Annual General Meeting, Apr 21, 2026 PCC Rokita SA, Annual General Meeting, Apr 21, 2026, at 10:00 Central European Standard Time. Reported Earnings • Nov 18
Third quarter 2025 earnings released: EPS: zł1.64 (vs zł0.38 loss in 3Q 2024) Third quarter 2025 results: EPS: zł1.64 (up from zł0.38 loss in 3Q 2024). Revenue: zł414.5m (down 9.8% from 3Q 2024). Net income: zł32.6m (up zł40.0m from 3Q 2024). Profit margin: 7.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance. Announcement • Nov 11
PCC Rokita SA to Report Q3, 2025 Results on Nov 13, 2025 PCC Rokita SA announced that they will report Q3, 2025 results on Nov 13, 2025 New Risk • Aug 28
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.1% net profit margin). Reported Earnings • Aug 22
Second quarter 2025 earnings released: EPS: zł0.27 (vs zł1.50 in 2Q 2024) Second quarter 2025 results: EPS: zł0.27 (down from zł1.50 in 2Q 2024). Revenue: zł449.6m (down 12% from 2Q 2024). Net income: zł5.36m (down 82% from 2Q 2024). Profit margin: 1.2% (down from 5.8% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Announcement • Aug 20
PCC Rokita SA to Report First Half, 2025 Results on Aug 20, 2025 PCC Rokita SA announced that they will report first half, 2025 results on Aug 20, 2025 Buy Or Sell Opportunity • Jun 30
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to zł66.10. The fair value is estimated to be zł82.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.5% over the last 3 years. Earnings per share has declined by 39%. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 7.0% per annum over the same time period. New Risk • May 30
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin). Reported Earnings • May 22
First quarter 2025 earnings released: EPS: zł0.14 (vs zł0.82 in 1Q 2024) First quarter 2025 results: EPS: zł0.14 (down from zł0.82 in 1Q 2024). Revenue: zł508.5m (up 3.4% from 1Q 2024). Net income: zł2.87m (down 83% from 1Q 2024). Profit margin: 0.6% (down from 3.3% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Announcement • Mar 31
PCC Rokita SA, Annual General Meeting, Apr 24, 2025 PCC Rokita SA, Annual General Meeting, Apr 24, 2025. Reported Earnings • Mar 28
Full year 2024 earnings released: EPS: zł5.83 (vs zł13.49 in FY 2023) Full year 2024 results: EPS: zł5.83 (down from zł13.49 in FY 2023). Revenue: zł1.79b (down 25% from FY 2023). Net income: zł115.8m (down 57% from FY 2023). Profit margin: 6.5% (down from 11% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 17
Third quarter 2024 earnings released: zł0.38 loss per share (vs zł1.50 profit in 3Q 2023) Third quarter 2024 results: zł0.38 loss per share (down from zł1.50 profit in 3Q 2023). Revenue: zł459.8m (down 10% from 3Q 2023). Net loss: zł7.44m (down 125% from profit in 3Q 2023). Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Oct 08
Consensus EPS estimates fall by 27% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from zł2.14b to zł1.95b. EPS estimate also fell from zł5.24 per share to zł3.80 per share. Net income forecast to shrink 33% next year vs 29% growth forecast for Chemicals industry in Poland . Consensus price target down from zł97.79 to zł93.32. Share price was steady at zł79.70 over the past week. Reported Earnings • Aug 22
Second quarter 2024 earnings released: EPS: zł1.50 (vs zł0.76 in 2Q 2023) Second quarter 2024 results: EPS: zł1.50 (up from zł0.76 in 2Q 2023). Revenue: zł508.4m (down 9.3% from 2Q 2023). Net income: zł29.7m (up 97% from 2Q 2023). Profit margin: 5.8% (up from 2.7% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Reported Earnings • May 19
First quarter 2024 earnings released: EPS: zł0.82 (vs zł7.08 in 1Q 2023) First quarter 2024 results: EPS: zł0.82 (down from zł7.08 in 1Q 2023). Revenue: zł491.9m (down 37% from 1Q 2023). Net income: zł16.4m (down 88% from 1Q 2023). Profit margin: 3.3% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 10% per year. Announcement • Apr 26
PCC Rokita SA, Annual General Meeting, May 20, 2024 PCC Rokita SA, Annual General Meeting, May 20, 2024, at 11:00 Central European Standard Time. Reported Earnings • Mar 21
Full year 2023 earnings released: EPS: zł13.49 (vs zł34.00 in FY 2022) Full year 2023 results: EPS: zł13.49 (down from zł34.00 in FY 2022). Revenue: zł2.39b (down 24% from FY 2022). Net income: zł267.8m (down 60% from FY 2022). Profit margin: 11% (down from 22% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 16
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: zł512.3m (down 36% from 3Q 2022). Net income: zł29.8m (down 80% from 3Q 2022). Profit margin: 5.8% (down from 18% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.6%. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 23
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: zł560.7m (down 22% from 2Q 2022). Net income: zł15.1m (down 87% from 2Q 2022). Profit margin: 2.7% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 5.0% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 21
First quarter 2023 earnings released First quarter 2023 results: Revenue: zł780.0m (up 12% from 1Q 2022). Net income: zł140.5m (up 13% from 1Q 2022). Profit margin: 18% (in line with 1Q 2022). Revenue is expected to decline by 5.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.9%. Valuation Update With 7 Day Price Move • May 05
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to zł124, the stock trades at a trailing P/E ratio of 3.6x. Average forward P/E is 16x in the Chemicals industry in Poland. Total returns to shareholders of 359% over the past three years. Reported Earnings • Mar 24
Full year 2022 earnings released: EPS: zł34.00 (vs zł21.02 in FY 2021) Full year 2022 results: EPS: zł34.00 (up from zł21.02 in FY 2021). Revenue: zł3.14b (up 43% from FY 2021). Net income: zł675.1m (up 62% from FY 2021). Profit margin: 22% (up from 19% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 72% per year whereas the company’s share price has increased by 68% per year. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to zł137, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 7x in the Chemicals industry in Poland. Total returns to shareholders of 487% over the past three years. Reported Earnings • Nov 16
Third quarter 2022 earnings released Third quarter 2022 results: Revenue: zł802.5m (up 48% from 3Q 2021). Net income: zł146.5m (up 91% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Nov 13
Third quarter 2022 earnings released Third quarter 2022 results: Revenue: zł802.5m (up 48% from 3Q 2021). Net income: zł146.5m (up 91% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Aug 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to zł71.50, the stock trades at a trailing P/E ratio of 2.8x. Average forward P/E is 14x in the Chemicals industry in Poland. Total returns to shareholders of 87% over the past three years. Reported Earnings • Aug 23
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: zł714.2m (up 28% from 2Q 2021). Net income: zł117.4m (up 30% from 2Q 2021). Profit margin: 16% (in line with 2Q 2021). Over the next year, revenue is expected to shrink by 11% compared to a 11% growth forecast for the Chemicals industry in Poland. Reported Earnings • May 20
First quarter 2022 earnings released First quarter 2022 results: Revenue: zł697.4m (up 41% from 1Q 2021). Net income: zł123.9m (up 78% from 1Q 2021). Profit margin: 18% (up from 14% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.1% compared to a 17% growth forecast for the industry in Poland. Price Target Changed • Apr 27
Price target increased to zł126 Up from zł53.20, the current price target is provided by 1 analyst. New target price is 38% above last closing price of zł91.00. Stock is up 24% over the past year. The company posted earnings per share of zł21.02 last year. Upcoming Dividend • Apr 19
Upcoming dividend of zł13.23 per share Eligible shareholders must have bought the stock before 26 April 2022. Payment date: 05 May 2022. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of Polish dividend payers (7.1%). In line with average of industry peers (3.2%). Reported Earnings • Mar 18
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: zł21.02 (up from zł5.91 in FY 2020). Revenue: zł2.20b (up 49% from FY 2020). Net income: zł417.3m (up 256% from FY 2020). Profit margin: 19% (up from 8.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 22%. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 13
Third quarter 2021 earnings released The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł541.9m (up 59% from 3Q 2020). Net income: zł76.7m (up 162% from 3Q 2020). Profit margin: 14% (up from 8.6% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Aug 21
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł559.4m (up 70% from 2Q 2020). Net income: zł90.1m (up zł76.0m from 2Q 2020). Profit margin: 16% (up from 4.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Price Target Changed • May 27
Price target increased to zł75.20 Up from zł53.20, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of zł73.00. Stock is up 62% over the past year. Upcoming Dividend • Apr 29
Upcoming dividend of zł3.67 per share Eligible shareholders must have bought the stock before 05 May 2021. Payment date: 14 May 2021. Trailing yield: 4.7%. Lower than top quartile of Polish dividend payers (5.2%). Higher than average of industry peers (2.4%). Reported Earnings • Mar 19
Full year 2020 earnings released: EPS zł5.91 (vs zł4.70 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: zł1.48b (down 1.1% from FY 2019). Net income: zł117.4m (up 26% from FY 2019). Profit margin: 8.0% (up from 6.3% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 26
New 90-day high: zł73.60 The company is up 55% from its price of zł47.60 on 27 November 2020. The Polish market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Feb 02
New 90-day high: zł65.80 The company is up 52% from its price of zł43.40 on 04 November 2020. The Polish market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is zł26.46 per share. Announcement • Feb 01
PCC Rokita SA to Report Q2, 2021 Results on Aug 18, 2021 PCC Rokita SA announced that they will report Q2, 2021 results on Aug 18, 2021 Is New 90 Day High Low • Jan 07
New 90-day high: zł56.80 The company is up 24% from its price of zł45.70 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is zł24.99 per share. Is New 90 Day High Low • Dec 04
New 90-day high: zł49.10 The company is up 4.0% from its price of zł47.20 on 04 September 2020. The Polish market is up 6.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is zł22.34 per share. Reported Earnings • Nov 16
Third quarter 2020 earnings released: EPS zł1.47 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: zł341.8m (down 12% from 3Q 2019). Net income: zł29.2m (down 22% from 3Q 2019). Profit margin: 8.6% (down from 9.6% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 30
New 90-day low: zł41.40 The company is down 18% from its price of zł50.40 on 31 July 2020. The Polish market is down 15% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is down 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is zł22.52 per share. Price Target Changed • Oct 26
Price target raised to zł53.69 Up from zł49.20, the current price target is an average from 2 analysts. The new target price is 19% above the current share price of zł45.00. As of last close, the stock is down 9.6% over the past year. Is New 90 Day High Low • Sep 24
New 90-day low: zł42.10 The company is down 1.0% from its price of zł42.60 on 26 June 2020. The Polish market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is zł20.84 per share.